Hutchmed Drc Stock Current Valuation
| HCM Stock | USD 15.40 0.71 4.41% |
Valuation analysis of HUTCHMED DRC helps investors to measure HUTCHMED DRC's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 26th of February 2025, Enterprise Value Over EBITDA is likely to grow to 40.08. Also, Enterprise Value Multiple is likely to grow to 40.08. Fundamental drivers impacting HUTCHMED DRC's valuation include:
Overvalued
Today
Please note that HUTCHMED DRC's price fluctuation is not too volatile at this time. Calculation of the real value of HUTCHMED DRC is based on 3 months time horizon. Increasing HUTCHMED DRC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the HUTCHMED stock is determined by what a typical buyer is willing to pay for full or partial control of HUTCHMED DRC. Since HUTCHMED DRC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HUTCHMED Stock. However, HUTCHMED DRC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.4 | Real 13.09 | Target 46.75 | Hype 15.4 | Naive 17.25 |
The intrinsic value of HUTCHMED DRC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence HUTCHMED DRC's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of HUTCHMED DRC helps investors to forecast how HUTCHMED stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HUTCHMED DRC more accurately as focusing exclusively on HUTCHMED DRC's fundamentals will not take into account other important factors: HUTCHMED DRC Company Current Valuation Analysis
HUTCHMED DRC's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current HUTCHMED DRC Current Valuation | 1.98 B |
Most of HUTCHMED DRC's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HUTCHMED DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
HUTCHMED Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for HUTCHMED DRC is extremely important. It helps to project a fair market value of HUTCHMED Stock properly, considering its historical fundamentals such as Current Valuation. Since HUTCHMED DRC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of HUTCHMED DRC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of HUTCHMED DRC's interrelated accounts and indicators.
Click cells to compare fundamentals
HUTCHMED Current Valuation Historical Pattern
Today, most investors in HUTCHMED DRC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various HUTCHMED DRC's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of HUTCHMED DRC current valuation as a starting point in their analysis.
HUTCHMED DRC Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, HUTCHMED DRC has a Current Valuation of 1.98 B. This is 86.25% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 88.12% higher than that of the company.
HUTCHMED Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HUTCHMED DRC's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HUTCHMED DRC could also be used in its relative valuation, which is a method of valuing HUTCHMED DRC by comparing valuation metrics of similar companies.HUTCHMED DRC is currently under evaluation in current valuation category among its peers.
HUTCHMED DRC Current Valuation Drivers
We derive many important indicators used in calculating different scores of HUTCHMED DRC from analyzing HUTCHMED DRC's financial statements. These drivers represent accounts that assess HUTCHMED DRC's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of HUTCHMED DRC's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 5.4B | 5.7B | 2.6B | 3.1B | 2.7B | 3.3B | |
| Enterprise Value | 5.2B | 5.4B | 2.3B | 2.9B | 2.6B | 3.3B |
HUTCHMED DRC ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, HUTCHMED DRC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to HUTCHMED DRC's managers, analysts, and investors.Environmental | Governance | Social |
HUTCHMED Fundamentals
| Return On Equity | -0.0544 | ||||
| Return On Asset | -0.059 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 1.98 B | ||||
| Shares Outstanding | 170.94 M | ||||
| Shares Owned By Insiders | 0.12 % | ||||
| Shares Owned By Institutions | 4.05 % | ||||
| Number Of Shares Shorted | 413.18 K | ||||
| Price To Earning | 335.94 X | ||||
| Price To Book | 3.64 X | ||||
| Price To Sales | 4.42 X | ||||
| Revenue | 838 M | ||||
| Gross Profit | (47.45 M) | ||||
| EBITDA | 25.53 M | ||||
| Net Income | 100.78 M | ||||
| Cash And Equivalents | 829.71 M | ||||
| Cash Per Share | 4.91 X | ||||
| Total Debt | 86.13 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 0.87 X | ||||
| Cash Flow From Operations | 219.26 M | ||||
| Short Ratio | 4.64 X | ||||
| Earnings Per Share | (0.25) X | ||||
| Target Price | 26.19 | ||||
| Number Of Employees | 1.97 K | ||||
| Beta | 0.73 | ||||
| Market Capitalization | 2.7 B | ||||
| Total Asset | 1.28 B | ||||
| Retained Earnings | (870.87 M) | ||||
| Working Capital | 693.81 M | ||||
| Current Asset | 187.47 M | ||||
| Current Liabilities | 96.7 M | ||||
| Net Asset | 1.28 B |
About HUTCHMED DRC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HUTCHMED DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HUTCHMED DRC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HUTCHMED DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out HUTCHMED DRC Piotroski F Score and HUTCHMED DRC Altman Z Score analysis. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth (0.43) | Return On Assets |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.